Selective serotonin reuptake inhibitors in pediatric psychopharmacology: A review of the evidence

Journal of Pediatrics

Volumn 148, Issue 2, 2006, Pages 158-165

  Hammerness, Paul G ^a   Vivas, Fé M ^a   Geller, Daniel A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY DISORDER; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DRUG ACTIVATION; DRUG ANTAGONISM; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MONITORING; DRUG POTENTIATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAINTENANCE THERAPY; MAJOR DEPRESSION; META ANALYSIS; MYOCLONUS; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SEROTONIN SYNDROME; SLEEP DISORDER; SUICIDAL IDEATION; SYSTEMATIC REVIEW; TIC; VIVID DREAM;

EID: 33344470275     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.09.028     Document Type: Article

References (80)

1. S. West, V. King, T.S. Carey, K.N. Lohr, N. McKoy, S.F. Sutton Systems to rate the strength of scientific evidence (Evidence Report/Technology Assessment 47) 2002 Agency for Healthcare Research and Quality Rockville, MD
2. J.M. McClellan, J.S. Werry Evidence-based treatments in children and adolescent psychiatry an inventory J Am Acad Child Adolesc Psychiatry 42 2003 1388 1400
3. D. Coghill Evidence based psychopharmacology for children and adolescents Curr Opin Psychiatry 15 2002 361 368
4. Agency for Healthcare Research and Quality Treatment of ADHD 1999 Agency for Healthcare Research and Quality Rockville, MD
5. M.S. Gould, T. Greenberg, D.M. Velting, D. Shaffer Youth suicide risk and preventive interventions a review of the past 10 years J Am Acad Child Adolesc Psychiatry 42 2003 386 405
6. P.J. Ambrosini, K. Dineen Wagner, J. Biederman, I. Glick, C. Tan, J. Elia Multicenter open-label sertraline study in adolescent outpatients with major depression J Am Acad Child Adolesc Psychiatry 38 1999 566 572
7. B.J. McConville, K.L. Minnery, M.T. Sorter, S.A. West, L.M. Friedman, K. Christian An open study of the effects of sertraline on adolescent major depression J Child Adolesc Psychopharmacol 6 1996 41 51
8. F. Rey-Sanchez, J.R. Gutierrez-Casares Paroxetine in children with major depressive disorder an open trial J Am Acad Child Adolesc Psychiatry 36 1997 1443 1447
9. G. Emslie, J. Rush, W. Weinberg, R. Kowatch, C. Hughes, T. Carmody A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression Arch Gen Psychiatry 54 1997 1031 1037
10. G.J. Emslie, J.H. Heiligenstein, K.D. Wagner, S.L. Hoog, D.E. Ernest, E. Brown Fluoxetine for acute treatment of depression in children and adolescents a placebo-controlled, randomized clinical trial J Am Acad Child Adolesc Psychiatry 41 2002 1205 1215
11. R.A. Kowatch, T.J. Carmody, G.J. Emslie, J.W. Rintelmann, C.W. Hughes, A.J. Rush Prediction of response to fluoxetine and placebo in children and adolescents with major depression a hypothesis-generating study J Affect Disord 54 1999 269 276
12. G.J. Emslie, J.H. Heiligenstein, S.L. Hoog, K.D. Wagner, R.L. Findling, J.T. McCracken Fluoxetine treatment for prevention of relapse of depression in children and adolescents a double-blind, placebo-controlled study J Am Acad Child Adolesc Psychiatry 43 2004 1397 1405
13. Treatment for Adolescents With Depression Study Team (TADS) Treatment for adolescents with depression study rationale, design and methods J Am Acad Child Adolesc Psychiatry 42 2003 531 542
14. C.W. Hughes, G.J. Emslie, M.L. Crismon, K. Wagner, B. Birmaher, B. Geller The Texas children's medication algorithm project report of the Texas consensus conference panel onmedication treatment of childhood major depressive disorder J Am Acad Child Adolesc Psychiatry 38 1999 1442 1454
15. American College of Neuropsychopharmacology Executive summary preliminary report of the task force on SSRIs and suicidal behavior in youth 2004 American College of Neuropsychopharmacology Nashville, TN
16. U.S. Food and Drug Administration. http://www.fda.gov/bbs/topics/ANSWERS/ 2003/ANS01256.html; 2003.
17. K.D. Wagner, A.S. Robb, R.L. Findling, J. Jin, M.M. Gutierrez, W.E. Heydorn A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents Am J Psychiatry 161 2004 1079 1083
18. K.D. Wagner, P. Ambrosini, M. Rynn, C. Wohlberg, R. Yang, M.S. Greenbaum Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder two randomized controlled trials JAMA 290 2003 1033 1041
19. C.L. Donnelly A comparison of the response to sertraline in children and adolescents with major depressive disorder 2003 American Academy of Child and Adolescent Psychiatry Miami Beach, FL
20. M.B. Keller, N.D. Ryan, M. Strober, R.G. Klein, S.P. Kutcher, B. Birmaher Efficacy of paroxetine in the treatment of adolescent major depression a randomized controlled trial J Am Acad Child Adolesc Psychiatry 40 2001 762 772
21. A. Braconnier, R. Le Coent, D. Cohen, D.S. Group Paroxetine versus clomipramine in adolescents with severe major depression a double-blind, randomized, multicenter trial J Am Acad Child Adolesc Psychiatry 42 2003 22 29
22. D. Geller, T. Spencer Obsessive-compulsive disorder A. Martin L. Scahill D.S. Charney J.F. Leckman Pediatric psychopharmacology principles and practice 2002 Oxford University Press Oxford, UK
23. D.A. Geller, J. Biederman, S.E. Stewart, B. Mullin, C. Farrell, K.D. Wagner Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder is the use of exclusion criteria empirically supported in randomized clinical trials? J Child Adolesc Psychopharmacol 13 2003 S19 S29
24. M.R. Liebowitz, S.M. Turner, J. Piacentini, D.C. Beidel, S.R. Clarvit, S.O. Davies Fluoxetine in children and adolescents with OCD a placebo-controlled trial J Am Acad Child Adolesc Psychiatry 41 2002 1431 1438
25. D.A. Geller, S.L. Hoog, J.H. Heiligenstein, R.K. Ricardi, R. Tamura, S. Kluszynski Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents a placebo-controlled clinical trial J Am Acad Child Adolesc Psychiatry 40 2001 773 779
26. M.A. Riddle, E.A. Reeve, J.A. Yaryura-Tobias, H.M. Yang, J.L. Claghorn, G. Gaffney Fluvoxamine for children and adolescents with obsessive-compulsive disorder a randomized, controlled, multicenter trial J Am Acad Child Adolesc Psychiatry 40 2001 222 229
27. Emslie G, Wagner K, Birmaher B, Geller D, Riddle M, Carpenter D. Safety and efficacy of paroxetine in the treatment of children and adolescents with OCD. Presented at the 153rd annual meeting of the American Psychiatric Association, Chicago, 2000.
28. Geller D, Biederman J, Emslie G, Carpenter D, Gallagher D, Wagner K. Comorbid psychiatric illness and response to treatment in pediatric OCD. Presented at the 154th annual meeting of the American Psychiatric Association, New Orleans, 2001.
29. Geller DA, Wagner KD, Emslie GJ, Murphy TK, Gallagher D, Gardiner C, et al. Efficacy of paroxetine in pediatric OCD: results of a multicenter study. Presented at the 155th annual meeting of the American Psychiatric Association, Philadelphia, 2002.
30. J. Alderman, R. Wolkow, M. Chung, H. Johnston Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression pharmacokinetics, tolerability, and efficacy J Am Acad Child Adolesc Psychiatry 37 1998 386 394
31. J.S. March, J. Biederman, R. Wolkow, A. Safferman, J. Mardekian, E.H. Cook Sertraline in children and adolescents with obsessive-compulsive disorder a multicenter randomized control trial JAMA 280 1998 1752 1756
32. E.H. Cook, K. Wagner, J.S. March, J. Biederman, P. Landau, R. Wolkow Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder J Am Acad Child Adolesc Psychiatry 40 2001 1175 1181
33. J.S. March Cognitive-behavioral psychotherapy for children and adolescents with OCD a review and recommendations for treatment J Am Acad Child Adolesc Psychiatry 34 1995 7 18
34. K.D. Wagner, E.H. Cook, H. Chung, M. Messig Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder J Child Adolesc Psychopharmacol 13 2003 S53 S60
35. D.A. Geller, J. Biederman, E.S. Stewart, B. Mullin, A. Martin, T. Spencer Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder Am J Psychiatry 160 2003 1919 1928
36. March JS. Pediatric OCD Treatment Study (POTS). Presented at the 156th annual meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 2003.
37. B. Birmaher, D.A. Axelson, K. Monk, C. Kalas, D.B. Clark, M. Ehmann Fluoxetine for the treatment of childhood anxiety disorders J Am Acad Child Adolesc Psychiatry 42 2003 415 423
38. The Research Unit on Pediatric Psychopharmacology Anxiety Disorders Study Group Fluvoxamine for the treatment of anxiety disorders in children and adolescents N Engl J Med 344 2001 1279 1285
39. B. Birmaher, D.A. Brent, R.S. Benson Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders J Am Acad Child Adolesc Psychiatry 37 1998 63S 83S
40. H. Leonard, J. March, K. Rickler, A. Allen Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents J Am Acad Child Adolesc Psychiatry 36 1997 725 736
41. R.S. Diler, L. Tamam, A. Avci Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy J Clin Psychopharmacol 20 2000 586 587
42. K. Manassis, R. Menna Depression in anxious children possible factors in comorbidity Depress Anxiety 10 1999 18 24
43. K.M. Lubell, M.H. Swahn, A.E. Crosby, S.R. Kegler Methods of suicide among persons aged 10-19 years-United States, 1992-2001 MMWR 53 2004 471 473 Available online at http://www.cdc.gov/mmwr/PDF/wk/mm5322.pdf
44. R.D. Gibbons, K. Hur, D.K. Bhaumik, J.J. Mann The relationship between antidepressant medication use and rate of suicide Arch Gen Psychiatry 62 2005 165 172
45. M. Olfson, D. Shaffer, S.C. Marcus, T. Greenberg Relationship between antidepressant medication treatment and suicide in adolescents Arch Gen Psychiatry 60 2003 978 982
46. R.J. Valuck, A.M. Libby, M.R. Sills, A.A. Giese, R.R. Allen Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder a propensity-adjusted retrospective cohort study CNS Drugs 18 2004 1119 1132
47. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder (revision) Am J Psychiatry 157 2000 1 45
48. T.E. Wilens, J. Biederman, A. Kwon, R. Chase, L. Greenberg, E. Mick A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors J Child Adolesc Psychopharmacol 13 2003 143 152
49. G.A. Carlson, E. Mick Drug-induced disinhibition in psychiatrically hospitalized children J Child Adolesc Psychopharmacol 13 2003 153 163
50. B. Geller, L. Fox, M. Fletcher Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds J Am Acad Child Adolesc Psychiatry 32 1993 43 50
51. B. Geller, B. Zimerman, M. Williams, K. Bolhofner, J.L. Gang Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder Am J Psychiatry 158 2001 125 127
52. J. Luby, C. Mrakotsky Depressed preschoolers with bipolar family history a group at high risk for later switching to mania? J Child Adolesc Psychopharmacol 13 2003 187 197
53. A. Martin, C. Young, J.F. Leckman, C. Mukonoweshuro, R. Rosenheck, L. Douglas Age effects of antidepressant-induced manic conversion Arch Pediatr Adolesc Med 158 2004 773 780
54. R.J. Baldessarini, G.L. Faedda, J. Hennen Risk of mania with antidepressants Arch Pediatr Adolesc Med 159 2005 298 299
55. H.J. Gijsman, J.R. Geddes, J.M. Rendell, W.A. Nolen, G.M. Goodwin Antidepressants for bipolar depression a systematic review of randomized, controlled trials Am J Psychiatry 161 2004 1537 1547
56. R.M. Hirschfeld, C.L. Bowden, M.J. Gitlin, P.E. Keck, R.H. Perlis, T. Suppes Practice guidelines for the treatment of patients with bipolar disorder (revision) Am Psychiatr Association 2002
57. C. Henry, J. Demotes-Mainard Avoiding drug-induced switching in patients with bipolar depression Drug Saf 26 2003 337 351
58. D.F. Papolos Switching, cycling, and antidepressant-induced effects on cycle frequency and course of illness in adult bipolar disorder a brief review and commentary J Child Adolesc Psychopharmacol 13 2003 165 171
59. R.S. Tamada Treatment emergent affective switch a controlled study Bipolar Disord 6 2004 333 337
60. M. Pao, T. Tipnis Serotonin syndrome after sertraline overdose in a 5-year-old girl Arch Pediatr Adolesc Med 151 1997 1064 1067
61. R.S. Diler, A.Y. Yolga, A. Avci Fluoxetine-induced extrapyramidal symptoms in an adolescent a case report Swiss Med Wkly 132 2002 125 126
62. N. Ghaziuddin, A. Iqbal, S. Khetarpal Myoclonus during prolonged treatment with sertraline in an adolescent patient J Child Adolesc Psychopharmacol 11 2001 199 202
63. K.B. Jones-Fearing SSRI and EPS with fluoxetine J Am Acad Child Adolesc Psychiatry 35 1996 1107 1108
64. C.F. Baldassano, C.J. Truman, A. Nierenberg, S.N. Ghaemi, G.S. Sachs Akathisia a review and case report following paroxetine treatment Compr Psychiatry 37 1996 122 124
65. E.J. Garland, E.A. Baerg Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents J Child Adolesc Psychopharmacol 11 2001 181 186
66. M.B. Lake, B. Birmaher, S. Wassick, K. Mathos, A.K. Yelovich Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence J Child Adolesc Psychopharmacol 10 2000 35 38
67. J.W. Calhoun, D.D. Calhoun Prolonged bleeding time in a patient treated with sertraline Am J Psychiatry 153 1996 443
68. S. Dalton, C. Johansen, L. Mellemkjaer, B. Norgard, H. Sorensen, J. Olsen Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding a population-based cohort study Arch Intern Med 163 2003 59 64
69. J. de Jong, P. van den Berg, H. Tobi, L. de Jong Combined use of SSRIs and NSAIDS increases the risk of gastrointestinal adverse effects Br J Clin Pharmacol 55 2003 591 595
70. R. Ramasubbu Cerebrovascular effects of selective serotonin reuptake inhibitors a systematic review J Clin Psychiatry 65 2004 1642 1653
71. R. Armitage, G. Emslie, J. Rintelmann The effect of fluoxetine on sleep EEG in childhood depression a preliminary report Neuropsychopharmacology 17 1997 241 245
72. M.A. Riddle Paroxetine and the FDA [letter] J Am Acad Child Adolesc Psychiatry 43 2004 128 130
73. D.A. Brent Paroxetine and the FDA [letter] J Am Acad Child Adolesc Psychiatry 43 2004 127 128
74. D.F. Connor Paroxetine and the FDA [letter] J Am Acad Child Adolesc Psychiatry 43 2004 127
75. R.C. Kessler, E.E. Walters Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey Depress Anxiety 7 1998 3 14
76. Centers for Disease Control and Prevention Methods of suicide among persons aged 10-19 years, United States 1992-2001 MMWR 53 2004 22
77. M.A. Rynn, L. Siqueland, K. Rickels Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder Am J Psychiatry 158 2001 2008 2014
78. J.T. Walkup, M. Labellarte, M.A. Riddle, D.S. Pine, L. Greenhill, R. Klein Fluvoxamine for the treatment of anxiety disorders in children and adolescents N Engl J Med 344 2001 1279 1285
79. J.S. Carlson, T.R. Kratochwill, H.F. Johnston Sertraline treatment of 5 children diagnosed with selective mutism a single-case research trial J Child and Adolesc Psychopharmacol 9 1999 293 306
80. B. Black, T. Uhda Treatment of elective mutism with fluoxetine a double-blind, placebo-controlled study J Am Acad Child and Adolesc Psychiatry 33 1994 1000 1006